EUVIMEDEUVIMED entdecken
Leserbrief

Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Anastasios Koulaouzidis iD, Wojciech Marlicz iD

Alimentary Pharmacology & Therapeutics · 08.10.2026

DOI: 10.1111/apt.71020 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 08.10.2026. Verfasst von Anastasios Koulaouzidis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

enhanced liver fibrosisliver fibrosisdiagnostic accuracymetabolic dysfunction‐associated steatotic liver diseasenon‐invasive tests

Autor:innen und Institutionen

  • Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark.
  • Department of Gastroenterology, Pomeranian Medical University in Szczecin (PUM), Szczecin, Poland.
  • Endoklinika, the Center for Digestive Diseases, Szczecin, Poland.

ORCID-Profile: Anastasios Koulaouzidis, Wojciech Marlicz

Zitieren

APA

Koulaouzidis, A., & Marlicz, W. (2026). Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71020

Vancouver

Koulaouzidis A, Marlicz W. Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71020

BibTeX
@article{Koulaouzidis2026,
  author = {Koulaouzidis, Anastasios and Marlicz, Wojciech},
  title = {Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71020}
}
Kostenlos starten →